| Current Price | $77.63 | Mkt Cap | $29.3B |
|---|---|---|---|
| Open | $74.26 | P/E Ratio | 153.95 |
| Prev. Close | $77.63 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $74.23 - $78.03 | Volume | 1,981,990 |
| 52-Wk Range | $66.89 - $164.86 | Avg. Daily Vol. | 4,145,952 |
A medical device company focused on the design, development and commercialization of continuous glucose monitoring systems for people with diabetes.
| Current Price | $77.63 | Mkt Cap | $29.3B |
|---|---|---|---|
| Open | $74.26 | P/E Ratio | 153.95 |
| Prev. Close | $77.63 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $74.23 - $78.03 | Volume | 1,981,990 |
| 52-Wk Range | $66.89 - $164.86 | Avg. Daily Vol. | 4,145,952 |
The best Bull and Bear pitches based on recency and number of recommendations.
From Fidelity and Zacks October 2021Revenue Growth (5YR) = 36.8%Rev Change (Last Qtr vs Prior year Qtr) = 31.7%Price/Sales (TTM) = 24.8
The company is having a great year, but based on its price-to-earnings ratio and its PEG, it's still a bit overpriced compared to its peers.
Read the most recent pitches from players about DXCM.
Recs
DZBV216
(< 20)
Submitted: 6/13/2022 10:22:35 AM :
Start Price:
$70.15
NASDAQ:DXCM Score:
+9.70
Trust in Nick Sciple
Recs
dpfriedman
(26.84)
Submitted: 1/28/2022 3:42:07 PM :
Start Price:
$102.41
NASDAQ:DXCM Score:
-10.93
Leader of the space for testing Diabetes and Americans are getting fatter everyday.
Recs
chessNstocks
(< 20)
Submitted: 10/29/2021 6:28:36 AM :
Start Price:
$145.00
NASDAQ:DXCM Score:
-30.04
From Fidelity and Zacks October 2021
Revenue Growth (5YR) = 36.8%
Rev Change (Last Qtr vs Prior year Qtr) = 31.7%
Price/Sales (TTM) = 24.8
Find the members with the highest scoring picks in DXCM.
ardys13 (< 20) Score: +7,959.34
The Score Leader is the player with the highest score across all their picks in DXCM.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| ardys13 | < 20 | 2/9/2009 |
|
1Y | $0.93 | +8,303.78% | +344.45% | +7,959.34 | 1 Comment | |
| bigrick22 | < 20 | 3/24/2008 |
|
NS | $1.00 | +7,673.50% | +196.63% | +7,476.87 | 0 Comment | |
| CleverKat | 58.35 | 3/24/2008 |
|
NS | $1.07 | +7,181.97% | +193.40% | +6,988.57 | 0 Comment | |
| cpalerm | 84.89 |
|
|
5Y | $1.08 | +7,097.69% | +389.34% | +6,708.35 | 1 Comment | |
| MEGIN7790 | < 20 | 4/4/2008 |
|
NS | $1.11 | +6,887.42% | +187.76% | +6,699.65 | 0 Comment | |
| LazyTimeMoney | 69.72 | 4/7/2008 |
|
NS | $1.26 | +6,069.44% | +187.28% | +5,882.17 | 0 Comment | |
| jabrink | 77.67 | 4/7/2008 |
|
3W | $1.27 | +6,032.94% | +187.05% | +5,845.89 | 0 Comment | |
| GriffinRex | 90.10 | 4/8/2008 |
|
3M | $1.29 | +5,914.31% | +190.26% | +5,724.05 | 0 Comment | |
| cash4metoo | 62.92 | 5/28/2009 |
|
1Y | $1.34 | +5,722.85% | +325.94% | +5,396.91 | 0 Comment | |
| YahooSIRIous | 92.91 | 7/13/2009 |
|
5Y | $1.34 | +5,711.96% | +333.87% | +5,378.09 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
